Veracyte Inc

NASDAQ:VCYT  
58.08
-0.48 (-0.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.86B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$32.42 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$63.52
50-Day MA$58.96
200-Day MA$41.11
See more pivots

Veracyte, Inc. Stock, NASDAQ:VCYT

6000 Shoreline Court, Suite 300, South San Francisco, California 94080
United States of America
Phone: +1.650.243.6300
Number of Employees: 354

Description

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.